share_log

Morgan Stanley Maintains Equal-Weight on C4 Therapeutics, Raises Price Target to $8

Moomoo 24/7 ·  Feb 26 10:42

Morgan Stanley analyst Terence Flynn maintains C4 Therapeutics (NASDAQ:CCCC) with a Equal-Weight and raises the price target from $1 to $8.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment